- Home
- CLNN vs HBIO Comparison
CLNN vs HBIO Comparison
Compare CLNN & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- HBIO
- Stock Information
- Founded
- CLNN 2012
- HBIO 1901
- Country
- CLNN United States
- HBIO United States
- Employees
- CLNN N/A
- HBIO N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- CLNN Health Care
- HBIO Industrials
- Exchange
- CLNN Nasdaq
- HBIO Nasdaq
- Market Cap
- CLNN 23.1M
- HBIO 19.6M
- IPO Year
- CLNN N/A
- HBIO 2000
- Fundamental
- Price
- CLNN $3.70
- HBIO $0.40
- Analyst Decision
- CLNN Strong Buy
- HBIO Buy
- Analyst Count
- CLNN 5
- HBIO 2
- Target Price
- CLNN $40.00
- HBIO $3.00
- AVG Volume (30 Days)
- CLNN 56.5K
- HBIO 1.1M
- Earning Date
- CLNN 08-06-2025
- HBIO 08-07-2025
- Dividend Yield
- CLNN N/A
- HBIO N/A
- EPS Growth
- CLNN N/A
- HBIO N/A
- EPS
- CLNN N/A
- HBIO N/A
- Revenue
- CLNN $350,000.00
- HBIO $91,397,000.00
- Revenue This Year
- CLNN N/A
- HBIO N/A
- Revenue Next Year
- CLNN $1,753.57
- HBIO $9.75
- P/E Ratio
- CLNN N/A
- HBIO N/A
- Revenue Growth
- CLNN N/A
- HBIO N/A
- 52 Week Low
- CLNN $2.28
- HBIO $0.28
- 52 Week High
- CLNN $6.96
- HBIO $3.60
- Technical
- Relative Strength Index (RSI)
- CLNN 46.64
- HBIO 40.82
- Support Level
- CLNN $3.53
- HBIO $0.42
- Resistance Level
- CLNN $3.81
- HBIO $0.48
- Average True Range (ATR)
- CLNN 0.21
- HBIO 0.04
- MACD
- CLNN -0.07
- HBIO -0.01
- Stochastic Oscillator
- CLNN 24.64
- HBIO 2.27
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.